Martha Goldberg Aronson bought $142k of CNMD
director at CONMED Corp. 2,000 shares at an average of $70.98, traded May 6, 2024, filed May 8, 2024.
Score components
- +15RoleDirector
- +11Trade size$142k at market
- +8Relative to holdingsFirst purchase: no shares before this trade
- +8Price context48% below the 52-week high
- +15Cluster4 insiders buying within 14 days
- 0Repeat buyingFirst buy in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m +10.1%, 3m -4.0%, 6m +9.6%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001127602-24-014593, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| May 6, 2024 | POpen-market purchase Common Stockindirect: by IRA | +2,000 | $70.98 | $142k | 2,000 | May 8, 2024 |
Related signals
Other insiders at CONMED Corp and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 15Weak | CONMED Corp | Richard Glaze Chief Information Officer | $11k 257 shares | -100% | |
| 33Weak | CONMED Corp | Todd W Garner Executive Vice President & CFO | $151k 3,500 shares | -66% | |
| 30Weak | CNMDsell CONMED Corp | Charles Farkas director | $107k 2,000 shares | -12% | |
| 47Moderate | CNMDsell CONMED Corp | Todd W Garner Executive Vice President & CFO | $31k 598 shares | -100% | |
| 33Weak | CNMDsell CONMED Corp | Charles Farkas director | $228k 4,000 shares | -20% | |
| 35Weak | CNMDsell CONMED Corp | Richard Glaze Chief Information Officer | $17k 257 shares | -100% | |
| 39Weak | CNMDsell CONMED Corp | Stanley W Peters III President AS and AET | $287k 4,000 shares | -98% | |
| 51Moderate | CONMED Corp | David M Bronson director | $97k 1,350 shares | +9% | |
| 56Moderate | CONMED Corp | Barbara J Schwarzentraub director | $100k 1,442 shares | - | |
| 71Notable | CONMED Corp | Pat Beyer Chief Operating Officer | $205k 3,000 shares | +38% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.